Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Strategies to build trust and recruit African American and Latino community residents for health research: a cohort study
source: Clinical and Translational Science
year: 2015
authors: Ibrahima C. Sankaré, Rachelle Bross, Arleen F. Brown, Homero E. del Pino, Loretta F. Jones, D’Ann M. Morris, Courtney Porter, Aziza Lucas-Wright, Roberto Vargas, Nell Forge, Keith C. Norris, Katherine L. Kahn
summary/abstract:Background:
This study used Community Partnered Participatory Research (CPPR) to address low participation of racial and ethnic minorities in medical research and the lack of trust between underrepresented communities and researchers.
Methods:
Using a community and academic partnership in July 2012, residents of a South Los Angeles neighborhood were exposed to research recruitment strategies: referral by word-of-mouth, community agencies, direct marketing, and extant study participants.
Results:
Among 258 community members exposed to recruitment strategies, 79.8% completed the study. Exposed individuals identifi ed their most important method for learning about the study as referral by study participants (39.8%), community agencies (30.6%), word-of-mouth (17.5%), or direct marketing promotion (12.1%). Study completion rates varied by recruitment method: referral by community agencies (88.7%), referral by participants (80.4%), direct marketing promotion (86.2%), word of mouth (64.3%).
Conclusions:
Although African American and Latino communities are often described as diffi cult to engage in research, we found high levels of research participation and completion when recruitment strategies emerged from the community itself. This suggests recruitment strategies based on CPPR principles represent an important opportunity for addressing health disparities and our high rates of research completion should provide optimism and a road map for next steps.
DOI: 10.1111/cts.12273
read more full text
Related Content
-
Global Blood Therapeutics Receives EMA PRIME Designation for GBT440 for the Treatment of Sickle Cell Disease (SCD)GBT440 is First Potential Treatment for ...
-
Review Board Finds Global Blood’s Sickle Cell Disease Therapy Voxelotor Is SafeAn independent review board has found Gl...
-
Roald Dahl’s Marvellous Children’s Charity “Everyone’s Business” campaignhttps://www.youtube.com/watch?v=VqdP3Sxa...
-
Mount Sinai receives NIH grant to study use of inhaled corticosteroids for sickle cell treatmentThe Departments of Emergency Medicine an...
-
Gamida Cell to Present Data from NiCord® Programs at the 2018 BMT Tandem MeetingsGamida Cell, a leading cellular and immu...
-
Culturally competent strategies for recruitment and retention of African American populations into clinical trialsPurpose: To identify successful recrui...
-
Gene therapy may help cure sickle cell disease, study saysA gene therapy that could provide a perm...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.